share_log

メドレック---ストップ安売り気配、今期業績予想の下方修正

Medrexx - Stop selling at low prices, downward revision of financial estimates for this fiscal year.

Fisco Japan ·  00:43


Stop selling at lower prices is expected. The downward revision of financial estimates has been announced, causing negative sentiment. For the financial estimates in December 2024, the revenue has been revised downwards from 0.442 billion yen to 0.244 billion yen (a decrease of 44.8%), and the operating loss has been revised downwards from a deficit of 1.183 billion yen to a deficit of 1.298 billion yen. The company states that it no longer expects to record milestone revenue, product sales, and cost of goods manufactured in December 2024 due to the receipt of notification regarding the completion of the MRX-5LBT examination, which was a prerequisite for approval.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment